Christopher R. Moore

Christopher R. Moore

Partner, Silicon Valley

Chris Moore represents acquirors, targets, boards of directors, investment banks, and investors in complex domestic and cross-border merger and acquisition transactions as well as joint ventures, with a focus on the technology and life sciences sectors.

Chris's recent experience includes billions of dollars of M&A activity for some of the world's top technology and life sciences companies as well as investment banks in connection with their roles as financial advisors on M&A transactions.

Awards and recognitions

2018

Media, Technology, and Telecoms: Technology: Transactions
Legal 500 US

2018

Media, Technology, and Telecoms: Telecoms and Broadcast: Transactional
Legal 500 US

2018

Mergers & Acquisitions, Rising Star
Law360

Education and admissions

Education

J.D., University of California, Los Angeles, School of Law, 2008

B.A., University of California, Los Angeles, cum laude, 2004

Memberships

Member, Working Group for the ABA 2017 Strategic Buyer/Public Target M&A Deal Points Study

Review Team Member, ABA M&A Carveout Transactions Deal Points Study

Bar admissions and qualifications

California

New York

Representative experience

Walmart in its US$16bn acquisition of a majority stake in Flipkart.

Marvell Technology Group in its US$6bn acquisition of Cavium.

Synopsys in its US$565m acquisition of Black Duck Software and in its acquisitions of Protecode, Gold Standard Simulations, Cigital, and Codiscope.*

Dialog Semiconductor in its US$276m acquisition of Silego Technology.

Atlassian in its pending US$295m acquisition of OpsGenie.

Zulily in its US$2.4bn sale to Liberty Interactive Corporation.*

Eli Lilly in its US$960m acquisition of CoLucid Pharmaceuticals.*

XenoPort in its US$446.6m sale to Arbor Pharmaceuticals.*

*Matter handled prior to joining Hogan Lovells.

Loading data